Cargando…
The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2(V617F) mutated cells
The transcription factor NFE2 is overexpressed in most patients with myeloproliferative neoplasms (MPN). Moreover, mutations in NFE2, found in a subset of MPN patients, strongly predispose for transformation to acute leukemia. Transgenic mice overexpressing NFE2 as well as mice harboring NFE2 mutati...
Autores principales: | Staehle, Anne Marie, Peeken, Jan Caspar, Vladimirov, Georg, Hoeness, Mirjam Elisabeth, Bojtine Kovacs, Sarolta, Karantzelis, Nikolaos, Gruender, Albert, Koellerer, Christoph, Jutzi, Jonas Samuel, Pahl, Heike Luise, Staehle, Hans Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079541/ https://www.ncbi.nlm.nih.gov/pubmed/36709354 http://dx.doi.org/10.1038/s41375-023-01826-y |
Ejemplares similares
-
Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2(V617F)-driven myeloproliferative disease initiation in mice
por: Staehle, Hans F., et al.
Publicado: (2020) -
The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies
por: Staehle, Hans Felix, et al.
Publicado: (2021) -
Histone demethylase JMJD2C: epigenetic regulators in tumors
por: Zhang, Chengcheng, et al.
Publicado: (2017) -
The Functions of the Demethylase JMJD3 in Cancer
por: Sanchez, Anna, et al.
Publicado: (2021) -
The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition
por: Glaser, Simone F., et al.
Publicado: (2020)